Although cigarette smoking is a leading cause of preventable mortality, tobacco is consumed by approximately 22% of the adult population worldwide. Smoking is also a risk factor for cardiovascular disease, affects brain processing, and is a recognized risk factor for Alzheimer disease (AD). Tobacco toxins (e.g., nicotine at high levels) inhaled in smoke may cause disorders resulting in preclinical brain changes. Researchers suggest that there are differences in brain volume between smokers and non-smokers. This review examines these differences in brain grey matter volume (GMV). In March/April 2015, MedLine, Embase, and PsycINFO were searched using the terms: "grey matter" AND "voxel-based" AND "smoking" AND "cigarette". The 4 studies analyzed found brain GMV decreases in smokers compared to non-smokers. Furthermore, sex-specific differences were found; while the thalamus and cerebellum were affected in both sexes, decreased GMV in the olfactory gyrus was found only in male smokers. Age-group differences were also found, and these may suggest pre-existing abnormalities that lead to nicotine dependence in younger individuals. Only 1 study found a positive correlation between number of pack-years smoked and GMV. Smoking decreases GMV in most brain areas. This decrease may be responsible for the cognitive impairment and difficulties with emotional regulation found in smokers compared with non-smokers.

Department of Psychiatry 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague Czech Republic

Zobrazit více v PubMed

USDHHS. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Rockville, MD: Department of Health and Human Services; 2012.

Schmidt CO, Watzke AB, Schulz A, et al. [The lifetime prevalence of mental disorders in North-Eastern Germany]. Psychiatr Prax. 2013;40:192–99. [in German] PubMed

Mokdad A, Marks J, Stroup D, Gerberding J. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–45. PubMed

Ogden J. Addictive behaviours. In: Ogden J, editor. Health Psychology. 5th ed. Berkshire: Open University Press; 2012. pp. 66–100.

Reitz C, den Heijer T, van Duijn C. Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study. Neurology. 2007;69:998–1005. PubMed

Starr J, Deary I, Fox H, Whalley L. Smoking and cognitive change from age 11 to 66 years: A confirmatory investigation. Addict Behav. 2007;32:63–68. PubMed

Cadar D, Pikhart H, Mishra G, et al. The role of lifestyle behaviours on 20-year cognitive decline. J Aging Res. 2012;2012:304014. PubMed PMC

Almeida OP, Hulse GK, Lawrence D, Flicker L. Smoking as a risk factor for Alzheimer’s disease: Contrasting evidence from a systematic review of case-control and cohort studies. Addiction. 2001;97:15–28. PubMed

Tyas S, White L, Petrovitch H, et al. Mid-life smoking and late-life dementia: The Honolulu-Asia Aging Study. Neurobiol Aging. 2003;24:589–96. PubMed

Anstey K, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decilne: A meta-analysis of prospective studies. Am J Epidemiol. 2007;166:367–78. PubMed

Mendrek A, Monterosso J, Simon S, et al. Working memory in cigarette smokers: Comparison to non-smokers and effects of abstinence. Addict Behav. 2008;31:833–44. PubMed PMC

Swan G, Nessov-Schlaggar C. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17:259–73. PubMed

Good C, Johnsrude I, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage. 2001;14:21–36. PubMed

Lautenschlager N, Almeida O, Flicker L. Preventing dementia: Why we should focus on health promotion now. Int Psychogeriatr. 2003;15:111–19. PubMed

Liao Y, Tang J, Liu T, et al. Differences between smokers and non-smokers in regional GMVs: A voxel-based morphometry study. Addict Biol. 2010;17:977–80. PubMed

Zhong J, Shi H, Shen Y, et al. Voxelwise meta-analysis of grey matter anomalies in chronic cigarette smokers. Behavioural Brain Research. 2016;311:39–45. PubMed

Fritz H-C, Wittfeld K, Schmidt CO, et al. Current smoking and reduced GMV-a voxel-based morphometry study. Neuropsychopharmacology. 2014;39:2594–600. PubMed PMC

Franklin TR, Wetherhill RR, Jagannathan K, et al. The effects of chronic cigarette smoking on GMV: Influence of sex. PLoS One. 2014;9(8):e104102. PubMed PMC

Brody AL, Mandelkern MA, Jarvik ME, et al. Differences between smokers and nonsmokers in regional GMVs and densities. Biol Psychiatry. 2004;55(1):77–84. PubMed

Kühn S, Romanowski A, Schilling C, et al. Brain grey matter deficits in smokers: focus on the cerebellum. Brain Struct Funct. 2012;217:517–22. PubMed

Yu R, Zhao L, Lu L. Regional grey and white matter changes in heavy male smokers. PLoS One. 2011;6(11):e27440. PubMed PMC

Galinat J, Meisenzahl E, Jacobsen L, et al. Smoking and structural brain deficits: A volumetric MR investigation. Eur J Neurosci. 2006;24:1744–50. PubMed

Zhang X, Salmeron B, Ross T, et al. Factors underlying prefrontal and insula structural alterations in smokers. Neuroimage. 2011;54:42–48. PubMed PMC

Hanlon CA, Owens MM, Joseph JE, et al. Lower subcortical gray matter volume in both younger smokers and established smokers relative to non-smokers. Addict Biol. 2016;21(1):185–95. PubMed PMC

Xu J, Mendrek A, Cohen M, et al. Brain activity in cigarette smokers perfroming a working memory task: Effect of smoking abstinence. Biol Psychiatry. 2005;58:143–50. PubMed PMC

Wager T, Phan K, Taylor S, Liberzon I. Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002;16:331–48. PubMed

Parvaz M, Konova A, Tomasi D, et al. Structural integrity of the prefrontal cortex modulates electrocortical sensitivity to reward. J Cogn Neurosci. 2012;24:1560–70. PubMed PMC

ADHD and lifestyle habits in Czech adults, a national sample